varespladib

Ligand id: 9657

Name: varespladib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 111.62
Molecular weight 380.14
XLogP 2.39
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid
International Nonproprietary Names
INN number INN
8243 varespladib
Synonyms
compound 6m [PMID: 8978844] | LY315920 | S-5920 | varespladib methyl (A-002) | varespladib sodium (A-001)
Comments
Varespladib (LY315920) is a secretory phospholipase A2 (sPLA2) inhibitor [1-2] in clinical development. The administered form can be varespladib sodium (A-001, for intravenuous administration) or varespladib methyl (A-002, for oral administration). The history of varespladib's discovery and development is summarized in [3].
Database Links
BindingDB Ligand 50055366
CAS Registry No. 172732-68-2 (source: WHO INN record)
ChEMBL Ligand CHEMBL148674
GtoPdb PubChem SID 348353616
PubChem CID 155815
Search Google for chemical match using the InChIKey BHLXTPHDSZUFHR-UHFFFAOYSA-N
Search Google for chemicals with the same backbone BHLXTPHDSZUFHR
Search PubMed clinical trials varespladib
Search PubMed titles varespladib
Search PubMed titles/abstracts varespladib
Search UniChem for chemical match using the InChIKey BHLXTPHDSZUFHR-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone BHLXTPHDSZUFHR